-

President Biden, You Can't Vaccinate the World Without Breaking Patents, Says AHF

LOS ANGELES--(BUSINESS WIRE)--As the demand for COVID-19 vaccine booster shots is growing across wealthy countries, an already underwhelming progress in vaccinating the rest of the world is at grave risk of falling even further behind. Today, AIDS Healthcare Foundation (AHF) called on the Biden Administration to urgently declare an emergency and suspend patent protections on vaccines, so that they can be manufactured at high volumes across the world to meet the global demand.

“In a constantly evolving pandemic, where the world seems to be weeks, if not months, behind the virus at every turn, we have an urgent message for President Biden – the US must break the patents and invoke TRIPS* flexibilities now!” said AHF President Michael Weinstein. “We cannot vaccinate the world quickly enough without dispensing with every single barrier that stands in the way of dramatically increasing vaccine production – that means compulsory licensing and technology transfers.”

There are indications that the Administration might be walking back its prior commitment to keep supplying the rest of the world with vaccines while also ensuring the domestic demand for booster shots is met. If that happens, enormous swaths of the global population will be left unvaccinated or under-vaccinated, which would leave an opening for even more variants to arise.

*TRIPS refers to the WTO Agreement on Trade-Related Aspects of Intellectual Property Rights. It allows countries to suspend patent compliance during public health emergencies.

AIDS Healthcare Foundation (AHF), the largest global AIDS organization, currently provides medical care and/or services to over 1.6 million clients in 45 countries worldwide in the US, Africa, Latin America/Caribbean, the Asia/Pacific Region and Europe. To learn more about AHF, please visit our website: www.aidshealth.org, find us on Facebook: www.facebook.com/aidshealth and follow us on Twitter: @aidshealthcare and Instagram: @aidshealthcare

Contacts

US MEDIA CONTACT:
Ged Kenslea, Senior Director, Communications, AHF
+1.323.308.1833 work +1.323.791.5526 mobile
gedk@aidshealth.org

Denys Nazarov, Director of Global Policy &
Communications, AHF
+1 323.308.1829
denys.nazarov@ahf.org

AIDS Healthcare Foundation


Release Versions

Contacts

US MEDIA CONTACT:
Ged Kenslea, Senior Director, Communications, AHF
+1.323.308.1833 work +1.323.791.5526 mobile
gedk@aidshealth.org

Denys Nazarov, Director of Global Policy &
Communications, AHF
+1 323.308.1829
denys.nazarov@ahf.org

More News From AIDS Healthcare Foundation

AHF: Florida Lawmakers Reverse HIV Drug Cuts, Restoring Coverage for Thousands

TALLAHASSEE, Fla.--(BUSINESS WIRE)--Thousands of Floridians living with HIV will keep the medication that keeps them alive, after the Florida Legislature today passed a state budget that reverses this year's cuts to the AIDS Drug Assistance Program (ADAP). The budget returns eligibility to 400 percent of the federal poverty level, brings back the medications the Department of Health had dropped, including Biktarvy, funds the program with $75 million, and adds independent oversight. "This is wha...

AHF Calls for Access and Dignity on Menstrual Health Day

LOS ANGELES--(BUSINESS WIRE)--AIDS Healthcare Foundation (AHF) joins the global commemoration of Menstrual Health Day with events across nearly 50 countries, highlighting the importance of reducing period stigma and expanding access to affordable menstrual products—critical steps in protecting overall health and reducing vulnerability to HIV and other sexually transmitted infections. Menstrual Health Day is observed annually on May 28. Around the world, barriers to menstrual health continue to...

Ebola Crisis Exposes Failure of Current Global Health Architecture, says AHF

LOS ANGELES--(BUSINESS WIRE)--As Uganda and the Democratic Republic of the Congo (DRC) confront a rapidly evolving Ebola outbreak, AIDS Healthcare Foundation (AHF) warns that the crisis highlights persistent weaknesses in the world’s ability to respond quickly and equitably to emerging infectious disease threats. The current outbreak involves the Bundibugyo strain of Ebola virus, for which no approved vaccines or therapeutics currently exist, heightening concerns among global health officials a...
Back to Newsroom